LUNG
Pulmonx Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.21
−2.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.42x
- Price / sales
- 1.09x
- Price / cash flow
- -3.11x
Enterprise value
- Enterprise value
- $95.3M
- EV / sales
- 1.09x
- EV / EBITDA
- -2.21x
- EV / EBIT
- -2.06x
- Market cap
- $94.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026